✦ LIBER ✦

Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimer's disease

✍ Scribed by M. Mauri; A. Mancioli; V. Rebecchi; S. Corbetta; C. Colombo; G. Bono

Book ID: 109337448
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 93 KB
Volume: 114
Category: Article
ISSN: 0001-6314
DOI: 10.1111/j.1600-0404.2006.00660.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tolerability of switching from donepezil

Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease

✍ Gunhild Waldemar; Maritta Hyvärinen; Mette Krog Josiassen; Alex Kørner; Heikki L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

This study investigates the tolerability, safety and efficacy of abrupt or stepwise switching from donepezil to memantine treatment in patients with moderate-to-severe Alzheimer's disease (AD). Outpatients (Table 1), !50 years, with dementia of the Alzheimer's type (DSM-IV-TR), MMSE 18 and receiving

Improvement in behavioural symptoms in p

Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis

✍ S. Gauthier; H. Loft; J. Cummings 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Abstract ## Introduction Behavioural disturbances are a common and distressing aspect of Alzheimer's disease (AD). This pooled analysis evaluated the specific benefits of memantine on behavioural disturbances in patients with moderate to severe AD. ## Methods Data were pooled from six 24/28‐w

SELEGILINE IN THE TREATMENT OF BEHAVIOUR

SELEGILINE IN THE TREATMENT OF BEHAVIOURAL DISTURBANCE IN ALZHEIMER'S DISEASE

✍ BRIAN A. LAWLOR; PAUL S. AISEN; CYNTHIA GREEN; ELIZABETH FINE; JAMES SCHMEIDLER 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Objective. The purpose of this study was to examine the behavioural and cognitive eects of selegiline in a group of moderately behaviourally disturbed AD patients. Design. This was a 14-week randomized double-blind placebo-controlled study of selegiline (10 mg) and placebo. Setting. An outpatient

The relationship between extrapyramidal

The relationship between extrapyramidal signs and cognitive function in patients with moderate to severe Alzheimer's disease

✍ Dr. Marcus Richards; Declan McLoughlin; Raymond Levy 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 478 KB 👁 2 views

Detecting treatment effects with combina

Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease

✍ Ralf Ihl; Steven Ferris; Philippe Robert; Bengt Winblad; Serge Gauthier; Frank T 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

## Abstract ## Objective When complex cognitive functions are measured with multi‐item scales like the Alzheimer's Disease Assessment Scale – cognitive subscale (ADAS‐cog), it seems valuable information can be lost due to combination of the ADAS‐cog items results into a total score. We hypothesize

Anxiety and behavioural disturbance as m

Anxiety and behavioural disturbance as markers of prodromal Alzheimer's disease in patients with mild cognitive impairment

✍ Damien Gallagher; Robert Coen; Dana Kilroy; Kate Belinski; Irene Bruce; Davis Co 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

Depression and anxiety have been reported to be independently predictive of conversion to Alzheimer's disease (AD) in patients with mild cognitive impairment (MCI). Anxiety symptoms have been less well studied and findings in this regard have been inconsistent. The objectives of this study are to de